Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 46.20%27.49M | 319.80%14.08M | 38.88%5.59M | 14.41%6.65M | -78.99%1.18M | -47.18%18.8M | -28.72%3.35M | -63.11%4.03M | -37.85%5.81M | -47.21%5.62M |
| Cost of revenue | 72.50%28.94M | 123.80%10.28M | 68.22%7.88M | 39.58%5.16M | 47.83%5.63M | -1.63%16.78M | 43.63%4.59M | -16.20%4.69M | -7.60%3.69M | -14.47%3.81M |
| Gross profit | -171.70%-1.45M | 406.62%3.8M | -246.90%-2.29M | -29.55%1.49M | -345.75%-4.45M | -89.08%2.03M | -182.22%-1.24M | -112.43%-661K | -60.45%2.12M | -70.75%1.81M |
| Operating expense | -6.10%8.85M | -34.12%2.76M | 43.75%2.46M | 13.86%2.08M | -8.68%1.55M | 15.29%9.42M | 192.46%4.19M | -21.79%1.71M | 3.57%1.83M | -18.84%1.69M |
| Selling and administrative expenses | -4.05%9.04M | -35.05%2.67M | 57.14%2.72M | 10.82%2.08M | -7.69%1.57M | 15.31%9.42M | 184.90%4.11M | -22.57%1.73M | 2.46%1.88M | -18.31%1.7M |
| -General and administrative expense | -4.05%9.04M | -35.05%2.67M | 57.14%2.72M | 10.82%2.08M | -7.69%1.57M | 15.31%9.42M | 184.90%4.11M | -22.57%1.73M | 2.46%1.88M | -18.31%1.7M |
| Other operating expenses | ---- | 15.58%89K | ---- | ---- | ---- | ---- | --77K | ---- | ---- | ---- |
| Total other operating income | 19,300.00%194K | ---- | 1,405.88%256K | --0 | 145.45%27K | --1K | ---- | -61.36%17K | -26.47%50K | --11K |
| Operating profit | -39.23%-10.3M | 119.12%1.04M | -100.34%-4.75M | -303.81%-589K | -5,223.08%-5.99M | -171.33%-7.4M | -7,437.84%-5.43M | -175.81%-2.37M | -91.94%289K | -97.15%117K |
| Net non-operating interest income (expenses) | -278.72%-84K | 866.67%29K | -278.79%-59K | -127.03%-84K | -37.50%30K | 656.08%47K | 3K | 94.12%33K | 22.92%-37K | 108.70%48K |
| Non-operating interest income | -6.66%547K | -12.67%131K | -27.32%133K | 34.31%137K | -3.31%146K | 48.53%586K | 11.94%150K | 42.97%183K | 50.00%102K | 132.31%151K |
| Non-operating interest expense | 17.07%631K | -30.61%102K | 28.00%192K | 58.99%221K | 12.62%116K | 33.75%539K | 9.70%147K | 35.14%150K | 19.83%139K | 145.24%103K |
| Net investment income | -99.84%819 | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -41.27%-10.38M | 119.66%1.07M | -105.68%-4.81M | -367.06%-673K | -3,714.55%-5.96M | -167.53%-7.35M | -7,433.78%-5.43M | -174.36%-2.34M | -92.88%252K | -96.00%165K |
| Income tax | -171.79%-341K | -162.92%-341K | 0 | 0 | 0 | 392.53%475K | 542K | -67K | 0 | 0 |
| Net income | -28.33%-10.04M | 123.59%1.41M | -111.75%-4.81M | -367.06%-673K | -3,714.55%-5.96M | -172.54%-7.83M | -8,166.22%-5.97M | -172.23%-2.27M | -92.88%252K | -96.00%165K |
| Net income continuous operations | -28.33%-10.04M | 123.59%1.41M | -111.75%-4.81M | -367.06%-673K | -3,714.55%-5.96M | -172.54%-7.83M | -8,166.22%-5.97M | -172.23%-2.27M | -92.88%252K | -96.00%165K |
| Noncontrolling interests | -3K | -2K | -1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | -28.29%-10.04M | 123.62%1.41M | -111.70%-4.81M | -367.06%-673K | -3,714.55%-5.96M | -172.54%-7.83M | -8,166.22%-5.97M | -172.23%-2.27M | -92.88%252K | -96.00%165K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -28.29%-10.04M | 123.62%1.41M | -111.70%-4.81M | -367.06%-673K | -3,714.55%-5.96M | -172.54%-7.83M | -8,166.22%-5.97M | -172.23%-2.27M | -92.88%252K | -96.00%165K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -28.89%-0.0174 | 124.27%0.0025 | -111.72%-0.0083 | -400.00%-0.0012 | -3,533.33%-0.0103 | -6,850.00%-0.0135 | -10,400.00%-0.0103 | -172.69%-0.0039 | -93.44%0.0004 | -95.77%0.0003 |
| Diluted earnings per share | -28.89%-0.0174 | 124.27%0.0025 | -111.72%-0.0083 | -400.00%-0.0012 | -3,533.33%-0.0103 | -6,850.00%-0.0135 | -10,400.00%-0.0103 | -172.69%-0.0039 | -93.44%0.0004 | -95.77%0.0003 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.